In-vivo glutathione elevation protects against hydroxyl free radical- induced protein oxidation in rat brain

Neurochemistry International

Volumn 36, Issue 3, 2000, Pages 185-191

  Pocernich, C B ^a   La Fontaine, M ^a   Butterfield, D A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Antioxidant; Free radicals; Glutathione; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; CARBONYL DERIVATIVE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYDROXYL RADICAL; PROTEIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; SCAVENGING SYSTEM; SYNAPTIC MEMBRANE; SYNAPTOSOME;

ACETYLCYSTEINE; ANIMALS; BRAIN; FERROUS COMPOUNDS; GLUTATHIONE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MALE; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

ANIMALIA; RODENTIA;

EID: 0033967664     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00126-6     Document Type: Article

References (49)

1. Anderson M.E., Luo J. Glutathione therapy: from prodrugs to genes. Seminars in Liver Disease. 18:1998;415-424.
2. Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biology & Aging. 6:1989;593-597.
3. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Research Reviews. 25:1997;335-358.
4. Benzi G., Moretti A. Age and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biology & Medicine. 19:1995;77-101.
5. Bernard G.R., Lucht W.D., Niedermeyer M.E., Snapper J.R., Ogletree M.L., Brigham K.L. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. Journal of Clinical Investigation. 73:1984;1772-1784.
6. Butterfield D.A. β-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chemical Research & Toxicology. 10:(5):1997;495-506.
7. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Advances in Cell Aging & Gerontology. 2:1997;161-191.
8. Chang S.H., Wilken D.R. Participation of the unsymmetrical disulfide of coenzyme A and glutathione in an enzymatic sulfhydryl-disulfide interchange. I. Partial purification and properties of the bovine kidney enzyme. Journal of Biological Chemistry. 241:1966;4251-4260.
9. Carlberg I., Mannervik B. Purification by affinity chromatography of yeast glutathione reductase, the enzyme responsible for the NADPH-dependent reduction of the mixed disulfide of coenzyme A and glutathione. Biochimica et Biophysica Acta. 484:1977;268-274.
10. Cesarone C.F., Scarabelli L., Orunesu M., Bagnasco M., De Flora S. Effects of aminothiols in 2-acetylaminofluorene-treated rats. I. Damage and repair of liver DNA, hyperplastic foci, and zymbal gland tumors. In Vivo. 1:(2):1987;85-91.
11. Cooper J.J.L. Glutathione in the brain: disorders of glutathione metabolism. Barchi R.L., Kunk L.M. The Molecular and Genetic Basis of Neurological Disease. 1997;1195-1230 Butterworth-Heinemann, Boston.
12. Dringen R., Hamprecht B. N-acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain. Neuroscience Letters. 259:1999;79-82.
13. Droge W. Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetylcysteine. Pharmacology. 46:1993;61-65.
14. Eady J.J., Orta T., Dennis M.F., Stratford M.R.L., Peacock J.H. Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. British Journal of Cancer. 72:1995;1089-1095.
15. Ellis E.F., Dodson L.Y., Police R.J. Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger N-acetylcysteine following experimental traumatic brain injury. Journal of Neurosurgery. 75:1991;774-779.
16. Gillissen A., Jaworska M., Ortha M., Coffiner M., Maes P., App E.M., Cantin A.M., Schultze-Werninghaus G. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in-vitro. Respiratory Medicine. 91:1997;159-168.
17. Grdina D.J., Murley J.S., Roberts J.C. Effects of thiols on topoisomerase-II alpha activity and cell cycle progression. Cell Proliferation. 31:1998;217-229.
18. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Analytical Biochemistry. 106:1980;207-212.
19. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology & Medicine. 2nd ed. 1989;Clarendon Press, Oxford.
20. Hensley K., Hall N., Shaw W., Carney J.M., Butterfield D.A. Electron paramagnetic resonance investigation of free radical induced alterations in neocortical synaptosomal membrane protein infrastructure. Free Radical Biology & Medicine. 17:1994;321-331.
21. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Lovell M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. Journal of Neurochemistry. 65:1995;2146-2156.
22. Holoye P.Y., Duelge J., Hansen R.M., Ritch P.S., Anderson T. Prophylaxis of ifosfamide toxicity with oral acetylcysteine. Seminars in Oncology. 10:(Suppl. 1):1983;66-77.
23. Katzman R., Saitoh T. Advances in Alzheimer's disease. FASEB Journal. 5:(3):1991;278-286.
24. Keller J.N., Mark R.J., Bruce A.J., Blanc E., Rothstein J.D., Uchida K., Waeg G., Mattson M.P. 4-hydroxynonenal, an aldehyde product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997;685-696.
25. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. Journal of Neurochemistry. 69:1997;273-284.
26. Kish S.J., Morito C.L., Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochemical Pathology. 4:1985;23-28.
27. Knuckey N.W., Palm D., Primiano M., Epstein M.H., Johanson C.E. N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke. 26:1995;305-310.
28. Koppal T., Drake J., Butterfield D.A. In-vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage. Biochimica et Biophysica Acta. 1453:1999;407-411.
29. Koppal T., Drake J., Yatin S., Jordan B., Varadarajan S., Bettenhausen L., Butterfield D.A. Peroxynitrite-induced alterations in synaptosomal membrane proteins: Insight into oxidative stress in Alzheimer's disease. Journal of Neurochemistry. 72:(1):1999;310-317.
30. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modifies proteins. Methods of Enzymology. 233:1994;346-357.
31. Lovell M.A., Xie C., Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology. 51:1998;1562-1566.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
33. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehyde product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. Journal of Neurochemistry. 68:1997;255-264.
34. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. Journal of Neuroscience. 17:1997;1046-1054.
35. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology & Medicine. 23:(1):1997;134-147.
36. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiology of Aging. 19:1998;33-36.
37. Mattson M.P., Furukawa K., Bruce A.J., Mark R.J., Blanc E. Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. Wasco W., Tanzi R.E. Molecular Mechanisms of Dementia. 1996;103-143 Humana Press Inc, Totowa, NJ.
38. McLellan L., Lewis A.D., Hall D.J., Ansell J.D., Wolf C.R. Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrations. Carcinogenesis. 16:1995;2099-2166.
39. Montine K.S., Olson S.J., Amarnath V., Whetsell W.O. Jr, Graham D.G., Montine T.J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of apoE4. American Journal of Pathology. 150:1997;437-443.
40. Olney J.W., Zorumsky C., Price M.T., Labruyere J. L-cysteine, a bicarbonate sensitive endogenous excitotoxin. Science. 243:1990;596-599.
41. Perry T.L., Godin D.V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neuroscience Letters. 33:1982;305-310.
42. Prescot L.F., Park J., Ballantyne A., Adriaenssens P., Proudfoot A.T. Treatment of paracetamol (acetominophen) poisoning with N-acetylcysteine. Lancet. ii:1977;432-434.
43. Puka-Sundvall M., Eriksson P., Nilsson M., Sandberg M., Lehmann A. Neurotoxicity of cysteine: interaction with glutamate. Brain Research. 705:1995;65-70.
44. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. Journal of Neurochemistry. 68:1997;2092-2097.
45. Subramaniam R., Roediger F., Mattson M.P., Keller J.N., Waeg G., Butterfield D.A. The lipid peroxidation product 4-hydroxy-2-trans-nonenal alters conformation of cortical synaptosomal membrane proteins. Journal of Neurochemistry. 69:1997;1161-1169.
46. Testa R., Ghia M., Mattioli F., Borzone S., Caglieris S., Mereto E., Giannini E., Risso D. Effects of reduced glutathione and N-acetylcysteine on lidocaine metabolism in cimetidine treated rats. Fundamental Clinical Pharmacology. 12:1998;220-224.
47. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry. 27:1969;502-522.
48. Qiu Y., Bernier M., Hearse D.J. The influence of N-acetylcysteine on cardiac function and rhythm disorders during ischemia and reperfusion. Cardioscience. 1:1990;65-74.
49. Xie C., Lovell M.A., Markesbery W.R. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radical Biology & Medicine. 25:1998;979-988.